Research Report of Single-use Bioreactors Market | Growth | Industry Forecast to 2019-2025
Meticulous Research®
– leading global market research company is researching on Single-use Bioreactors Market titled- “Single-use Bioreactors
Market by Product
(Single-use Bioreactor, Media Bags), Usage (Lab-scale, Large-scale), Type
(Stirred tank, Bubble-Column), cell type (Mammalian, bacteria), application
(Bioproduction, Research), End user (Pharma & biotech, CROs)- Global
Forecast to 2025".
 |
| Single-use Bioreactors Market |
Governments in
developed as well as developing nations are offering funding for propagation of
biotechnology and biopharmaceutical research. For instance, in India, in 2017,
Department of Biotechnology (DBT) and World Bank initiated a program - Innovate
in India (I3) - to facilitate research related to the discovery of
biopharmaceuticals. Similarly, in the U.S., National Institute of Health (NIH)
collaborated with 11 biopharmaceutical companies to launch the “Partnership for
Accelerating Cancer Therapies (PACT)”, a five-year public-private research
collaboration. The aim of the collaboration is to develop immunotherapy for
cancers with total investment of $215 million. Furthermore, in Korea, the
government announced second Basic Development Plan for Bioengineering (2012).
According to which, the Korean government increased biotech investments to KRW
9.7 trillion ($8.35 billion) through 2016. In addition, Korean government
announced the “Government-Wide Mid- to Long-Term Action Plans to Promote
R&D for National Healthcare” in 2013 - to promote growth of biotechnology
and healthcare industry.
Single-Use
Bioreactor Systems Segment Dominated the Single-Use Bioreactors Market in 2018
Single-use bioreactor
system commanded the largest share of the single-use bioreactors market in 2018
due to its better flexibility, no sterilization demand, and low operational
cost without compromising the quality of the drug produced. This addresses the
complexities associated with multi‑drug manufacturing processes while providing
maximum savings on the time spent to prepare the bioreactor for the next batch.
Mammalian
Cells to Witness the Largest Demand Through 2025
Mammalian cells
commanded the largest share of single-use bioreactor market in 2018. This is
mainly attributed to proper protein folding, post-translational modifications,
and product assembly, which plays an important role to initiate complete
biological activity in humans.
Asia-Pacific:
The Fastest Growing Regional Market
North America
commanded the largest share of the global single-use bioreactors market in
2018, followed by Europe, Asia-Pacific, Latin America, and Middle East &
Africa. However, Asia-Pacific is the fastest growing regional market due to
accelerated economic growth of many countries in this region and growing
government focus on pharmaceutical research. In addition, government
initiatives to escalate the drug development process, rising public &
private funding for R&D, and rising contract research and manufacturing
activities - are the key factors propelling the growth of the Asia-Pacific
single-use bioreactors market.
Key
players in the Single-use Bioreactors Market
In the single-use bioreactors
market, the leading players are consistently developing new products with
improved performance, higher efficiency, and low operational costs. In March
2018, Sartorius Stedim Biotech launched ambr 250 high throughput (ht) perfusion
system for rapid cell culture perfusion process development for production of
therapeutic antibodies. Similarly, in April 2016, Merck Millipore launched
Mobius 1000-liter single-use bioreactor, which has greater flexibility and
continuity for scale-up. Furthermore, in November 2016, Finesse Solutions, Inc.
(U.S.), launched SmartVessel, a single-use 3-liter bioreactor vessel.
The key players operating in the global single-use bioreactors
market are GE Healthcare, Merck Group, Danaher Corporation, Sartorius AG,
Thermo Fisher Scientific Inc., Eppendorf
AG, Applikon Biotechnology B.V., Solaris Biotechnology SRL, Cellexus Ltd, CESCO
Bioengineering Co., Ltd., PBS Biotech, Inc., Pierre Guerin Technologies,
Distek, Inc., Parker-Hannifin Corporation, Celltainer Biotech B.V., and Infors
AG.
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Website: https://www.meticulousresearch.com/
Connect with us | LinkedIn | Twitter |
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Website: https://www.meticulousresearch.com/
Connect with us | LinkedIn | Twitter |
Comments
Post a Comment